Appendix 1 in the Supplementary File provides general information of the studies reviewed. The study populations were patients with HF and these studies were conducted between 2005 and 2020. From a total of 27 approved studies, 1 was conducted in Brazil (
5), 1 in Serbia (
23), 1 in Korea (
24), 1 in the Netherlands (
25), 1 in Italy (
26), 1 in Iran (
27), 1 in Singapore (
17), and 1 in Taiwan (
28). Other studies (
19,
29-
46) were conducted in the United States. The smallest number of participants in this review belongs to the study of Murray et al. and Barnason et al. with 44 patients (
31,
45), while the largest number of participants belongs to the study of McNaughton et al. with 705 patients (
34). A gender distribution with a minimum number of male participants (20.5%) was observed in the study of Murray et al. (
31), whereas the maximum number of male participants (75.5%) was observed in the study of Tung et al. (
28). Except for 2 studies in Asia (
24,
28) in which all participants were of Asian descent, other studies indicated that the majority of participants were African American (
30,
31,
36,
37,
39). Other studies reported the ethnicity of the participants separately, and most of the participants were white (
5,
29,
32-
35,
39-
42).
Among the studies, five were cohorts (
29,
31,
33,
34,
44). One of these studies (
31) investigated the factors associated with exacerbation of clinical symptoms and reduced quality of life in patients with HF. Two studies (
29,
34) examined the relationship between HL and mortality and the factors influencing hospitalization. In another study, the effect of self-efficacy on medication adherence and patients’ quality of life was measured (
44). The latest study (
33) also examined the effect of HL on adherence to medication and treatment. Thirteen studies (
5,
17,
19,
23-
25,
28,
32,
35,
36,
40,
41) were cross-sectional. In some studies, only the effect of HL on various factors influencing the quality of life was investigated (
23,
28,
32,
35,
36). In addition to this, some other studies assessed the effect of HL on adherence to treatment (
5,
24,
36,
40,
41). Another descriptive comparative study examined the effect of HL on quality of life, self-care and hospital stay (
39). Three other studies (
38,
42,
43) that were randomized clinical trials examined the effect of self-care education in HF patients on their treatment adherence and their quality of life. In 7 studies, the effect of self-efficacy on quality of life and adherent medication was investigated (
17,
19,
25-
27,
45,
46). Lastly, 1 post hoc analysis study (
30) was performed on a randomized controlled clinical trial and ascertained the effect of pharmacological education by a pharmacologist on adherence to treatment, HL, and the quality of life of people with HF (Appendix 1 in the Supplementary File).
The prevalence of inadequate and marginal HL was also examined in a number of studies. The test of functional HL in adult (TOFHLA) was the most common used questionnaire in many studies (
31,
32,
35,
36,
39,
41,
42). According to these studies, the prevalence of low HL ranged from 19.2% to 61%. This indicates that majority of these patients has inadequate HL. Moreover, another study (
37) showed 47.9% had low levels of HL, using TOFHLA. The study by Jovanic et al. (
23) reported the highest prevalence of poor HL, which assessed its patients via the European Health Literacy Questionnaire. This questionnaire examines the perception, availability, evaluation and implementation of health information in patients. Tung et al. (
28) also found a high prevalence of inadequate HL. Their results obtained from Taiwan Health Literacy Scale (THLS) questionnaire showed that 60% of HF patients in Taiwan had poor HL.
In general, all studies have shown that HF patients with adequate HL and self-care have a positive effect on medication adherence. In a study by Murray et al. (
31), it was found that poor HL tripled the risk of the non-adherence. Murray et al. reported that their HF patients with low levels of HL had been correlated with poor quality of life (
31). Improved medication adherence in relation to sufficient HL was further observed in other studies (
30,
33,
40,
41). The study by Como (
40) stated that adequate HL has a bilateral positive effect on self-efficacy and mental health of individuals, and this improvement in mental health increases the adherence to treatment in patients with HF. Another study (
33) found that higher literacy levels had reduced the likelihood of non-adherence to treatment in patients with HF (OR, 0.84; 95% CI, 0.74-0.9).
Good HL also enhances the quality of life of people with HF. The report obtained from RCT studies indicates that interventions of teaching health principles and self-care to patients has improved patients’ quality of life (
38,
42). DeWalt et al. (
38) stated that increasing the number of training sessions increases the patients’ knowledge over hear failure, which finally improves the quality of life. Other studies (
36,
39,
41) also confirmed these findings and disclosed the positive and significant correlation between self-care and HF knowledge, that ultimately led to improvements in patients’ quality of life. Another study (
24) showed the effect of high levels of HL on seeking social supports and practicing self-care. A positive effect was observed in all aspects of quality of life. High levels of HL were found to improve mental and physical states in these patients (
23).
The impact of HL on mortality and hospitalization of HF patients was also assessed. In fact, patients with poor HL have higher mortality rates. Peterson et al. (
29) reported a significant increase in risk of mortality in patients with inadequate HL. This result was also supported in another study (
5). The length of hospital stay tend to prolong and recovery is less expected in patients with poor HL (
28,
34).
The present review also examined the role of self-efficacy in quality of life and adherence to treatment. Overall, self-efficacy has a significant prediction from quality of life and medication adherence. Several studies in this area (
27,
43,
45) have shown that enhancements in self-efficacy made patients to more willingly follow their treatment, and lead to experience of higher quality of life, and lower hospitalization rates among the HF population. An association between higher rates comorbidity has been found with low self-efficacy in patients (
26). Diabetes patients with comorbid HF have also confirmed the effective and positive role of self-efficacy in their quality of life (
46). Only one study did not find a statistical significance effect of self-efficacy on improved health status (
17). But other studies emphasized the positive and significant effect of self-efficacy on the lives of patients with HF (
19,
25,
27,
44).